What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary areas of study are Surgery, Hepatectomy, Survival rate, Metastasis and Cancer.
His Surgery study combines topics in areas such as Colorectal cancer and General surgery.
His studies deal with areas such as Hepatocellular carcinoma, Internal medicine, Survival analysis and Intrahepatic Cholangiocarcinoma as well as Hepatectomy.
In his work, Disease is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine.
His Survival rate research incorporates themes from Prospective cohort study and Adjuvant therapy.
The Metastasis study combines topics in areas such as Rectum and Radiology.
His most cited work include:
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer: Analysis of 1001 Consecutive Cases (2816 citations)
- Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade (1295 citations)
- Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. (953 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Internal medicine, Hepatectomy, Gastroenterology and Radiology.
His biological study spans a wide range of topics, including Colorectal cancer and Metastasis.
His Colorectal cancer study incorporates themes from Prospective cohort study and Proportional hazards model.
His research brings together the fields of Oncology and Internal medicine.
As a member of one scientific family, he mostly works in the field of Hepatectomy, focusing on Survival rate and, on occasion, Adjuvant therapy.
His work carried out in the field of Radiology brings together such families of science as Stage, Bile duct, Carcinoma and Biliary tract.
He most often published in these fields:
- Surgery (56.54%)
- Internal medicine (30.37%)
- Hepatectomy (26.64%)
What were the highlights of his more recent work (between 2006-2021)?
- Surgery (56.54%)
- Hepatectomy (26.64%)
- Internal medicine (30.37%)
In recent papers he was focusing on the following fields of study:
Leslie H. Blumgart mainly focuses on Surgery, Hepatectomy, Internal medicine, Colorectal cancer and Gastroenterology.
His Surgery research is multidisciplinary, relying on both Malignancy and Metastasis.
His Metastasis study combines topics from a wide range of disciplines, such as Rectum and Univariate analysis.
The Hepatectomy study combines topics in areas such as Resection margin, Surgical oncology, Survival analysis and Retrospective cohort study.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Adjuvant therapy and Clinical trial.
His research in Colorectal cancer intersects with topics in Complication, Prospective cohort study, Proportional hazards model and Ablation.
Between 2006 and 2021, his most popular works were:
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure (801 citations)
- Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. (509 citations)
- Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. (342 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
His scientific interests lie mostly in Surgery, Hepatectomy, Internal medicine, Colorectal cancer and Survival rate.
His Surgery research includes themes of Malignancy and Metastasis.
His studies in Hepatectomy integrate themes in fields like Clinical trial, Gallbladder cancer, Randomized controlled trial, Retrospective cohort study and Surgical oncology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
His Colorectal cancer research incorporates themes from Prospective cohort study and Proportional hazards model.
His Survival rate research integrates issues from Angiosarcoma, Epithelioid hemangioendothelioma and Hemangioendothelioma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
